Patent ID: 11945874
Assignee: GENZYME CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The method of claim 1, wherein said antibody comprises heavy chain (H)-CDR1, H-CDR2, H-CDR3, and light chain (L)-CDR1, L-CDR2, and L-CDR3, comprising the amino acid sequences of:
a) SEQ ID NOs: 51, 59, 69, 29, 36, and 43, respectively;
b) SEQ ID NOs: 50, 60, 69, 29, 37, and 43, respectively;
c) SEQ ID NOs: 50, 61, 68, 29, 38, and 43, respectively;
d) SEQ ID NOs: 50, 61, 69, 29, 36, and 43, respectively;
e) SEQ ID NOs: 50, 62, 69, 29, 39, and 43, respectively;
f) SEQ ID NOs: 52, 61, 70, 30, 40, and 43, respectively;
g) SEQ ID NOs: 53, 63, 71, 31, 36, and 44, respectively;
h) SEQ ID NOs: 54, 64, 71, 31, 36, and 45, respectively;
i) SEQ ID NOs: 55, 63, 72, 31, 36, and 46, respectively;
j) SEQ ID NOs: 56, 65, 73, 32, 41, and 47, respectively;
k) SEQ ID NOs: 56, 65, 294, 32, 41, and 47, respectively; or
l) SEQ ID NOs: 56, 66, 74, 33, 41, and 48, respectively.